EP Patent

EP1115406A2 — Sustained release, and comfortable ophthalmic composition and method for ocular therapy

Assigned to Alcon Vision LLC · Expires 2001-07-18 · 25y expired

What this patent protects

Disclosed are reduced stinging, sustained release ophthalmic formulations. Also disclosed are methods of treatment comprising administering such formulations topically to the eye when in need thereof.

USPTO Abstract

Disclosed are reduced stinging, sustained release ophthalmic formulations. Also disclosed are methods of treatment comprising administering such formulations topically to the eye when in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number: EP1115406A2
Jurisdiction: EP
Classification: —
Expires: 2001-07-18
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Vision LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.